印度慢性病多发病的流行病学及其影响:系统回顾与荟萃分析。

Journal of multimorbidity and comorbidity Pub Date : 2024-06-05 eCollection Date: 2024-01-01 DOI:10.1177/26335565241258851
Roja Varanasi, Abhinav Sinha, Meenakshi Bhatia, Debadatta Nayak, Raj K Manchanda, Rajeev Janardhanan, John Tayu Lee, Simran Tandon, Sanghamitra Pati
{"title":"印度慢性病多发病的流行病学及其影响:系统回顾与荟萃分析。","authors":"Roja Varanasi, Abhinav Sinha, Meenakshi Bhatia, Debadatta Nayak, Raj K Manchanda, Rajeev Janardhanan, John Tayu Lee, Simran Tandon, Sanghamitra Pati","doi":"10.1177/26335565241258851","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This is the first systematic review and meta-analysis of the prevalence of multimorbidity, its risk factors including socioeconomic factors, and the consequences of multimorbidity on health systems and broader society in India.</p><p><strong>Methods: </strong>A systematic review of both published and grey literature from five databases (Medline, Embase, EBSCO, Scopus, and ProQuest) was conducted including original studies documenting prevalence or patient outcomes associated with multimorbidity among adults in India. We excluded studies that did not explicitly mention multimorbidity. Three independent reviewers did primary screening based on titles and abstracts followed by full-text review for potential eligibility. The risk of bias was independently assessed by two reviewers following the Appraisal Tool for Cross-Sectional Studies. We presented both qualitative and quantitative (through meta-analysis) summaries of the evidence. The protocol for this study was prospectively registered with PROSPERO (CRD42021257281).</p><p><strong>Results: </strong>The review identified 5442 articles out of which 35 articles were finally included in this study. Twenty-three studies were based on the primary data while 12 used secondary data. Eleven studies were conducted in hospital/primary care setting while 24 were community-based. The pooled prevalence of multimorbidity based on (n=19) studies included for meta-analysis was 20% (95% CI: 19% to 20%). The most frequent outcomes were increased healthcare utilization, reduced health-related quality of life, physical and mental functioning.</p><p><strong>Conclusion: </strong>We identified a wide variance in the magnitude of multimorbidity across age groups and regions with most of the studies from eastern India. Nation-wide studies, studies on vulnerable populations and interventions are warranted.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"14 ","pages":"26335565241258851"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155324/pdf/","citationCount":"0","resultStr":"{\"title\":\"Epidemiology and impact of chronic disease multimorbidity in India: a systematic review and meta-analysis.\",\"authors\":\"Roja Varanasi, Abhinav Sinha, Meenakshi Bhatia, Debadatta Nayak, Raj K Manchanda, Rajeev Janardhanan, John Tayu Lee, Simran Tandon, Sanghamitra Pati\",\"doi\":\"10.1177/26335565241258851\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>This is the first systematic review and meta-analysis of the prevalence of multimorbidity, its risk factors including socioeconomic factors, and the consequences of multimorbidity on health systems and broader society in India.</p><p><strong>Methods: </strong>A systematic review of both published and grey literature from five databases (Medline, Embase, EBSCO, Scopus, and ProQuest) was conducted including original studies documenting prevalence or patient outcomes associated with multimorbidity among adults in India. We excluded studies that did not explicitly mention multimorbidity. Three independent reviewers did primary screening based on titles and abstracts followed by full-text review for potential eligibility. The risk of bias was independently assessed by two reviewers following the Appraisal Tool for Cross-Sectional Studies. We presented both qualitative and quantitative (through meta-analysis) summaries of the evidence. The protocol for this study was prospectively registered with PROSPERO (CRD42021257281).</p><p><strong>Results: </strong>The review identified 5442 articles out of which 35 articles were finally included in this study. Twenty-three studies were based on the primary data while 12 used secondary data. Eleven studies were conducted in hospital/primary care setting while 24 were community-based. The pooled prevalence of multimorbidity based on (n=19) studies included for meta-analysis was 20% (95% CI: 19% to 20%). The most frequent outcomes were increased healthcare utilization, reduced health-related quality of life, physical and mental functioning.</p><p><strong>Conclusion: </strong>We identified a wide variance in the magnitude of multimorbidity across age groups and regions with most of the studies from eastern India. Nation-wide studies, studies on vulnerable populations and interventions are warranted.</p>\",\"PeriodicalId\":73843,\"journal\":{\"name\":\"Journal of multimorbidity and comorbidity\",\"volume\":\"14 \",\"pages\":\"26335565241258851\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155324/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of multimorbidity and comorbidity\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/26335565241258851\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of multimorbidity and comorbidity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26335565241258851","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目标:这是首次对印度的多病症患病率、其风险因素(包括社会经济因素)以及多病症对医疗系统和更广泛的社会造成的后果进行系统回顾和荟萃分析:我们对五个数据库(Medline、Embase、EBSCO、Scopus 和 ProQuest)中已发表的文献和灰色文献进行了系统综述,其中包括记录印度成人中多病症患病率或患者相关结果的原创研究。我们排除了未明确提及多病症的研究。三位独立审稿人根据标题和摘要进行初筛,然后进行全文审阅,以确定是否符合条件。偏倚风险由两名审稿人根据横断面研究评估工具进行独立评估。我们对证据进行了定性和定量(通过荟萃分析)总结。本研究的方案已在 PROSPERO(CRD42021257281)进行了前瞻性注册:综述共发现了 5442 篇文章,其中 35 篇最终被纳入本研究。23 项研究基于原始数据,12 项研究使用了二手数据。有 11 项研究在医院/初级医疗机构进行,24 项研究在社区进行。根据纳入荟萃分析的 19 项研究,多病共存率为 20%(95% CI:19% 至 20%)。最常见的结果是医疗保健使用增加、与健康相关的生活质量下降、身体和心理功能下降:我们发现不同年龄组和地区的多病症程度差异很大,其中大部分研究来自印度东部。有必要在全国范围内开展研究,并对弱势群体和干预措施进行研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Epidemiology and impact of chronic disease multimorbidity in India: a systematic review and meta-analysis.

Objectives: This is the first systematic review and meta-analysis of the prevalence of multimorbidity, its risk factors including socioeconomic factors, and the consequences of multimorbidity on health systems and broader society in India.

Methods: A systematic review of both published and grey literature from five databases (Medline, Embase, EBSCO, Scopus, and ProQuest) was conducted including original studies documenting prevalence or patient outcomes associated with multimorbidity among adults in India. We excluded studies that did not explicitly mention multimorbidity. Three independent reviewers did primary screening based on titles and abstracts followed by full-text review for potential eligibility. The risk of bias was independently assessed by two reviewers following the Appraisal Tool for Cross-Sectional Studies. We presented both qualitative and quantitative (through meta-analysis) summaries of the evidence. The protocol for this study was prospectively registered with PROSPERO (CRD42021257281).

Results: The review identified 5442 articles out of which 35 articles were finally included in this study. Twenty-three studies were based on the primary data while 12 used secondary data. Eleven studies were conducted in hospital/primary care setting while 24 were community-based. The pooled prevalence of multimorbidity based on (n=19) studies included for meta-analysis was 20% (95% CI: 19% to 20%). The most frequent outcomes were increased healthcare utilization, reduced health-related quality of life, physical and mental functioning.

Conclusion: We identified a wide variance in the magnitude of multimorbidity across age groups and regions with most of the studies from eastern India. Nation-wide studies, studies on vulnerable populations and interventions are warranted.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信